Xigduo® XR (dapagliflozin/metformin) – First-time authorized brand alternative

Site Logo

Get in touch with our sales team today

Fill out this form and we’ll get back to you shortly.

Need help or account access? View our support resources or sign in.

Xigduo^® XR (dapagliflozin/metformin) – First-time authorized brand alternative

January 3, 2024 - Prasco launched an authorized brand alternative of AstraZeneca’s Xigduo XR (dapagliflozin/metformin) extended-release tablets.

back to top